In the recent years, GlaxoSmithKline (GSK) has started to explore how data and analytics can be used across the organization to drive better efficiencies. Through the Singapore Data Science Consortium, GSK is now working with researchers from the Institute of Data Science at the National University of Singapore to develop predictive models to offer greater and more accurate insights; with the ultimate aim of having a better understanding of its customers.
Project Title: Increasing the Competitiveness of CEP
Done By: GlaxoSmithKline Pte Ltd (GSK), National University of Singapore (NUS), Singapore Data Science Consortium (SDSC)
Contact Person: Dr. Zhang Zhen, Data Scientist, SDSC
This research is supported by the National Research Foundation, Prime Minister’s Office, Singapore under its Industry Alignment Fund (Pre-positioning) Funding Initiative.